UPDATED Mar 26, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
NVDA | US$925.61 | 2.4% | 243.0% | US$2.3t | US$955.60 | PE76.5x | E22.8% | 0.02% | ||
AVGO | US$1,331.49 | 7.6% | 113.1% | US$626.4b | US$1,497.90 | PE53.3x | E23.4% | 1.6% | ||
AMD | US$177.87 | -2.0% | 88.1% | US$288.7b | US$196.09 | PE336.6x | E35.5% | n/a | ||
QCOM | US$167.07 | 1.8% | 37.7% | US$187.1b | US$164.13 | PE23.7x | E8.9% | 1.9% | ||
INTC | US$41.99 | -0.1% | 43.4% | US$176.9b | US$46.59 | PE105.1x | E31.3% | 1.2% | ||
AMAT | US$206.67 | 2.6% | 77.6% | US$173.2b | US$212.31 | PE24x | E6.2% | 0.8% | ||
TXN | US$167.91 | 0.7% | -5.4% | US$155.5b | US$169.10 | PE23.6x | E5.4% | 3.1% | ||
ARM | US$127.96 | 2.7% | n/a | US$142.2b | US$101.40 | PE1547.7x | E47.4% | n/a | ||
MU | US$118.80 | 26.4% | 100.4% | US$129.7b | US$123.03 | PS7.2x | E79.9% | 0.4% | ||
LRCX | US$967.23 | 3.9% | 99.4% | US$127.4b | US$912.75 | PE36.7x | E15.7% | 0.8% | ||
KLAC | US$688.42 | 1.1% | 85.6% | US$94.6b | US$663.24 | PE34.4x | E14.5% | 0.8% | ||
ADI | US$188.96 | -0.8% | 2.9% | US$94.5b | US$210.90 | PE33.3x | E12.0% | 1.9% | ||
NXPI | US$239.06 | 1.1% | 38.0% | US$61.6b | US$245.10 | PE21.9x | E8.9% | 1.7% | ||
MRVL | US$68.26 | 4.9% | 68.8% | US$57.3b | US$87.72 | PS10.7x | E58.0% | 0.4% | ||
MCHP | US$86.24 | -1.2% | 10.8% | US$47.4b | US$92.43 | PE19.8x | E-6.9% | 2.1% | ||
MPWR | US$666.49 | 2.5% | 40.3% | US$32.6b | US$756.42 | PE75.9x | E16.9% | 0.8% | ||
ON | US$72.89 | -1.6% | -4.8% | US$31.4b | US$88.86 | PE14.3x | E6.9% | n/a | ||
GFS | US$50.79 | -1.0% | -23.3% | US$28.7b | US$61.78 | PE27.5x | E17.1% | n/a | ||
ENTG | US$140.30 | 5.1% | 84.6% | US$21.4b | US$142.81 | PE117.1x | E41.6% | 0.3% | ||
SWKS | US$104.02 | 0.5% | -8.2% | US$16.8b | US$116.01 | PE18.4x | E11.0% | 2.6% | ||
TER | US$108.14 | 4.5% | 3.8% | US$16.7b | US$112.15 | PE36.9x | E20.8% | 0.4% | ||
FSLR | US$153.16 | 3.9% | -27.1% | US$16.5b | US$223.10 | PE19.7x | E29.0% | n/a | ||
ENPH | US$109.35 | 0.2% | -43.5% | US$15.1b | US$128.39 | PE33.8x | E16.4% | n/a | ||
ALAB | US$83.38 | n/a | n/a | US$13.0b | US$85.00 | PS109.8x | E102.7% | n/a |